Pohl A, Erichsen M, Stehr M, Hubertus J, Bergmann F, Kammer B, von Schweinitz D
Department of Pediatric Surgery, Dr. von Hauners' childrens hospital, Munich, Germany.
Department of Pediatric Surgery, Cnopf'sche Children's Clinic, Nuremberg, Germany.
Klin Padiatr. 2016 Apr;228(3):118-23. doi: 10.1055/s-0041-111175. Epub 2016 Feb 29.
Neuroblastoma is the second most common solid pediatric tumor and the most common cancer to be detected in children younger than 12 months of age. To date, 2 different staging systems describe the extent of the disease: the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Risk Group Staging System (INRGSS). The INRGSS-system is characterized by the presence or absence of so called image-defined risk factors (IDRFs), which are described as surgical risk factors. We hypothesized that IDRFs correlate with surgical complications, surgical radicality, local recurrence and overall survival (OS).
Between 2003 and 2010, 102 patients had neuroblastoma surgery performed in our department. We analyzed medical records for IDRF-status and above named data.
16 patients were IDRF-negative, whereas 86 patients showed one or more IDRF. Intra- or postoperative complications have been reported in 21 patients (21%). 19 of them showed one or more IDRF and 2 patients were IDRF-negative (p=n.s.). Patients who suffered from intra- or postoperative complications demonstrated a decreased OS (p=0.011). Statistical analysis revealed an inverse correlation between the extent of macroscopical removal and IDRF-status (p=0.001). Furthermore, the number of IDRFs were associated with a decreased likelihood of radical tumor resection (p<0.001). 19 patients had local recurrence; all of them were IDRF-positive (p=0.037).
Pediatric surgeons should consider IDRFs as a useful tool for risk assessment and therefore planning for neuroblastoma surgery.
神经母细胞瘤是儿童第二常见的实体瘤,也是12个月以下儿童中最常见的癌症。迄今为止,有两种不同的分期系统描述疾病的范围:国际神经母细胞瘤分期系统(INSS)和国际神经母细胞瘤风险组分期系统(INRGSS)。INRGSS系统的特点是存在或不存在所谓的影像定义风险因素(IDRFs),这些因素被描述为手术风险因素。我们假设IDRFs与手术并发症、手术根治性、局部复发和总生存期(OS)相关。
2003年至2010年期间,我们科室对102例神经母细胞瘤患者进行了手术。我们分析了病历中的IDRF状态及上述数据。
16例患者IDRF阴性,而86例患者显示有一个或多个IDRF。21例患者(21%)报告了术中或术后并发症。其中19例显示有一个或多个IDRF,2例患者IDRF阴性(p=无统计学意义)。发生术中或术后并发症的患者OS降低(p=0.011)。统计分析显示宏观切除范围与IDRF状态呈负相关(p=0.001)。此外,IDRF的数量与根治性肿瘤切除的可能性降低相关(p<0.001)。19例患者出现局部复发;所有患者均为IDRF阳性(p=0.037)。
小儿外科医生应将IDRFs视为风险评估以及神经母细胞瘤手术规划的有用工具。